Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza

Journal of Infectious Diseases

Volumn 207, Issue 5, 2013, Pages 709-720

  Kimberlin, David W ^a   Acosta, Edward P ^b   Prichard, Mark N ^a   Sánchez, Pablo J ^d   Ampofo, Krow ^e   Lang, David ^f   Ashouri, Negar ^g   Vanchiere, John A ⁱ   Abzug, Mark J ^j   Abughali, Nazha ^k   Caserta, Mary T ^l   Englund, Janet A ^m   Sood, Sunil K ⁿ   Spigarelli, Michael G ^o   Bradley, John S ^h   Lew, Judy ^p   Michaels, Marian G ^q   Wan, Wen ^r   Cloud, Gretchen ^c   Jester, Penelope ^a   Lakeman, Fred D ^a   Whitley, Richard J ^a   Giles, Dusty ^s   Cotton, Bari ^s   Judy, Sharon ^t   Cowie, Margaret ^t   Francis, Jeanne ^u   Evans, Candice ^f   O'donnell, Nan ^f   Shiraishi, Ofelia Vargas ^g   Latiolais, Lisa ⁱ   Aymami, Valeri ^j   Dole, Ken ^j   Gaultier, Julie ^k   Lofthus, Gerry ^v   Kinnunen, Diane ^m   Lacombe, Kirsten ^m   Stellato, Nancy ⁿ   Denlinger, Julie ^o   Hingtgen, Sara ^h   Mason, Christina ^p   Jeffrey, Noreen ^q   more..

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f MILLER CHILDREN S HOSPITAL   (United States)

^g CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^h RADY CHILDREN'S HOSPITAL   (United States)

ⁱ LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^j UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l UNIVERSITY OF ROCHESTER   (United States)

^m SEATTLE CHILDREN S HOSPITAL   (United States)

ⁿ DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^o CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^p UNIVERSITY OF FLORIDA   (United States)

^q UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^r VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^s UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^t UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^u UNIVERSITY OF UTAH   (United States)

^v UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

more..

Author keywords

antiviral resistance; antiviral treatment; influenza; Oseltamivir; Tamiflu

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; OSELTAMIVIR;

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ANTIVIRAL SUSCEPTIBILITY; AREA UNDER THE CURVE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG ERUPTION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; IC 50; INFANT; INFLUENZA; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; NONHUMAN; OPEN STUDY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEASONAL INFLUENZA; SEIZURE; TIME TO MAXIMUM PLASMA CONCENTRATION; VIRAL CLEARANCE; VIRUS ISOLATION; VIRUS LOAD; VOMITING;

ADMINISTRATION, ORAL; DRUG RESISTANCE, VIRAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; MALE; ORTHOMYXOVIRIDAE; OSELTAMIVIR;

EID: 84873694508     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis765     Document Type: Article

References (49)

1. Bhat N, Wright JG, Broder KR, et al. Influenza-Associated deaths among children in the United States, 2003-2004. N. Engl. J. Med 2005; 353:2559-67
2. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med 2000; 342:232-9
3. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N. Engl. J. Med 2000; 342:225-31
4. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004; 113:1758-64
5. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113:585-93
6. Hackett S, Hill L, Patel J, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 2009; 374:605
7. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N. Engl. J. Med 2009; 361:1935-44
8. Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N. Engl. J. Med 2010; 362:45-55
9. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009; 374:605-7
10. Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: An observational populationbased study. Lancet 2010; 376:1846-52
11. Cox CM, Blanton L, Dhara R, Brammer L, Finelli L. 2009 pandemic influenza A (H1N1) deaths among children-United States, 2009-2010. Clin. Infect. Dis 2011; 52(SUPPL1):S69-74
12. Randolph AG, Vaughn F, Sullivan R, et al. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 2011; 128:e1450-e1458
13. Lopez-Medina E, Ardura MI, Siegel JD, Brock E, Sanchez PJ. 2009 influenza A in infants hospitalized at younger than 6 months. J. Pediatr 2012; 160:626-631 e1
14. Acosta EP, Jester P, Gal P, et al. Oseltamivir dosing for influenza infection in premature neonates. J. Infect. Dis 2010; 202:563-6
15. Wilkinson DJ, Buttery JP, Andersen CC. Influenza in the neonatal intensive care unit. J. Perinatol 2006; 26:772-6
16. Sert A, Yazar A, Odabas D, Bilgin H. An unusual cause of fever in a neonate: Influenza A (H1N1) virus pneumonia. Pediatr. Pulmonol 2010; 45:734-6
17. Munoz FM, Campbell JR, Atmar RL, et al. Influenza A virus outbreak in a neonatal intensive care unit. Pediatr. Infect. Dis. J 1999; 18: 811-5
18. American Academy of Pediatrics. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics 2011; 128: 813-25
19. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-24
20. He G, Massarella J, Ward P. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin. Pharmacokinet. 1999; 37:471-84
21. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355:1845-50
22. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283:1016-24
23. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr. Infect. Dis. J 2001; 20:127-33
24. Heinonen S, Silvennoinen H, Lehtinen P, et al. Early oseltamivir treatment of influenza in children 1-3 years of age: A randomized controlled trial. Clin. Infect. Dis 2010; 51:887-94
25. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin. Infect. Dis 2007; 45:1568-75
26. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: Oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009; 4:e6051
27. Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: Opportunistic retrospective study of medical charts in China. BMJ 2010; 341:c4779
28. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: A meta-Analysis of eleven randomized clinical trials. Clin. Infect. Dis 2011; 53:277-9
29. US Food and Drug Administration. FDA issuance letter for Tamiflu, 2009. Accessed 8 September 2009. http://www.fda.gov/downloads/Drugs/DrugSafety/ InformationbyDrugClass/UCM153547.pdf
30. Centers for Disease Control and Prevention. Recommendations for use of antiviral medications for the management of influenza in children and adolescent for the 2009-2010 season-pediatric supplement for health care providers. 24 December 24 2009. http://www.cdc.gov/h1n1flu/recommendations-pediatric- supplement.htm. Accessed 29 December 2011
31. Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: Descriptive study. Lancet 2004; 364:759-65
32. Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: A prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J. Infect. Dis 2004; 189:440-9
33. Wiltshire H, Wiltshire B, Citron A, et al. Development of a highperformance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J. Chromatogr. B. Biomed. Appl 2000; 745:373-88
34. Ward CL, Dempsey MH, Ring CJ, et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J. Clin. Virol 2004; 29:179-88
35. Newton DW, Mellen CF, Baxter BD, Atmar RL, Menegus MA. Practical and sensitive screening strategy for detection of influenza virus. J. Clin. Microbiol 2002; 40:4353-6
36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10
37. Dawood FS, Jain S, Finelli L, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15
38. Stephenson I, Democratis J, Lackenby A, et al. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin. Infect. Dis 2009; 48:389-96
39. Standing JF, Nika A, Tsagris V, et al. Oseltamivir pharmacokinetics and clinical experience in neonates and infants during an outbreak of H1N1 influenza a virus infection in a neonatal intensive care unit. Antimicrob. Agents Chemother 2012; 56:3833-40
40. Yang D, Pearce RE, Wang X, Gaedigk R, Wan YJ, Yan B. Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin. Biochem. Pharmacol 2009; 77:238-47
41. Thorlund K, Awad T, Boivin G, Thabane L. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect Dis 2011; 11:134
42. Hatakeyama S, Sugaya N, Ito M, et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 2007; 297:1435-42
43. Harvala H, Gunson R, Simmonds P, Hardie A, Bennett S, Scott F, Roddie H, McKnight J, Walsh T, Rowney D, Clark A, Bremner J, Aitken C, Templeton K. The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in Scotland, November-December, 2009. Euro Surveill. 2010;15(14):pii=19536. Available online: Http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19536
44. Wang B, Dwyer DE, Blyth CC, et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res 2010; 87:16-21
45. Winzer R, Kanig N, Schneitler S, et al. Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int 2009; 106:770-6
46. Boivin G, Coulombe Z, Wat C. Quantification of the influenza virus load by real-Time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir. J. Infect. Dis 2003; 188:578-80
47. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin. Infect. Dis 2010; 50:850-9
48. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J. Infect. Dis 2009; 200:492-500
49. Ison MG, de Jong MD, Gilligan KJ, et al. End points for testing influenza antiviral treatments for patients at high risk of severe and lifethreatening disease. J. Infect. Dis 2010; 201:1654-62